retatrutide clinical trials south africa Lilly's 'triple G' agonist triumphs in Phase III trial, but AEs unnerve analysts Retatrutide Phase 3: TRIUMPH Program

Glucagon-like peptide 1 receptor agonists (GLP-1RAs), traditionally used in the treatment of type 2 diabetes, are becoming increasingly appreciated for their diverse applications

Novo Nordisk has already felt the pinch, cutting its 2025 sales growth outlook to 13-21% (from 16-24%) and operating profit growth to 16-24% (from 19-27%)

Furthermore, users have access to a team of experienced professionals, including doctors, psychologists, dietitians, and personal trainers, ensuring a holistic approach to weight management

, (LSM [95% ] : -1,68 [-1,91, -1,46] / -1,22 [-1,45, -1,00] /

During the titration period, doses of metformin and glimepiride were to be increased up to 2,000 mg/day and 4 mg/day, respectively

doi: 10.1007/s00125-016-3874-y